The DOI matches its Crossref record.
Plasma homocysteine in acute myocardial infarction: homocysteine‐lowering effect of folic acid
Abstract
Objectives. Moderate hyperhomocysteinaemia is an independent risk factor for cardiovascular disease which may be causal. We investigated whether the concentration of plasma homocysteine changes between the acute phase of myocardial infarction and follow‐up, and whether treatment with oral folic acid was effective in lowering homocysteine levels in patients with myocardial infarction. Design and subjects. Plasma total homocysteine levels 24–36 h (baseline) after onset of acute myocardial infarction were compared with the levels obtained at 6 weeks' follow‐up and with the levels in the controls. In the same patients, we studied the effect on plasma homocysteine of 6 weeks' treatment with daily oral folic acid doses of 2.5 or 10 mg compared to no treatment. Results. At baseline, 12 of 68 patients (18%) had moderate hyperhomocysteinaemia (>17.3 μmol L−1; P < 0.05). Between baseline and follow‐up, plasma homocysteine levels increased from 13.1 ± 4.6 to 14.8 ± 4.8 μmol L−1 (mean ± SD; P < 0.001). Treatment with nitroglycerin, streptokinase, beta blockers, or acetylsalicylic acid seemed not to have caused this change. Folic acid lowered plasma homocysteine in all but two of 33 treated patients with a mean decrease of 4.4 μmol L−1 (–27%; P < 0.001). There was no difference between the effect of 2.5 and 10 mg of folic acid. In the untreated group (n = 20), plasma homocysteine increased with a mean increase of 0.6 μmol L−1 (+ 4%; P < 0.05). Conclusions. Plasma homocysteine seems to increase in the post myocardial infarction period, the cause of which warrants further study. Folic acid appears to be an effective treatment for the reduction of both normal and increased plasma homocysteine concentrations in patients with myocardial infarction. This suggests that folic acid should be used for intervention when studying the effect of homocysteine‐lowering therapy on the risk on myocardial infarction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Homocysteine and Cardiovascular Disease
Refsum, H., Ueland, P. M., Nygård, O., & Vollset, S. E. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.31 · Cited by 2,180
Plasma Homocysteine as a Risk Factor for Vascular Disease: The European Concerted Action Project
Graham, I. M. (1997) · JAMA · doi:10.1001/jama.1997.03540460039030 · Cited by 1,738
Grundy, S. M., Pasternak, R., Greenland, P., Smith, S., & Fuster, V. (1999) · Circulation · doi:10.1161/01.cir.100.13.1481 · Cited by 1,315
Selhub, J. (1999) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.19.1.217 · Cited by 1,186
Blount, B. C., Mack, M. M., Wehr, C. M., MacGregor, J. T., Hiatt, R. A., Wang, G., Wickramasinghe, S. N., Everson, R. B., & Ames, B. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3290 · Cited by 1,139
Metadata
- Authors
- LANDGREN, F., ISRAELSSON, B., LINDGREN, A., HULTBERG, B., ANDERSSON, A., & Brattström, L.
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 1995-04
- Volume
- 237
- Issue
- 4
- Pages
- 381-388
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W1998033890
- Cited by
- 203
- References
- 0
- FWCI
- 16.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Plasma homocysteine in acute myocardial infarction: homocysteine‐lowering effect of folic acid. https://app.cochat.ai/papers/10.1111/j.1365-2796.1995.tb01190.x
- The paper
- LANDGREN, F., ISRAELSSON, B., LINDGREN, A., HULTBERG, B., ANDERSSON, A., & Brattström, L. (1995). Plasma homocysteine in acute myocardial infarction: homocysteine‐lowering effect of folic acid. Journal of Internal Medicine. https://doi.org/10.1111/j.1365-2796.1995.tb01190.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.